Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 5
1946 27
1947 17
1948 21
1949 21
1950 51
1951 56
1952 43
1953 33
1954 33
1955 40
1956 36
1957 36
1958 30
1959 29
1960 37
1961 39
1962 39
1963 56
1964 54
1965 64
1966 72
1967 95
1968 100
1969 83
1970 105
1971 104
1972 116
1973 99
1974 96
1975 102
1976 98
1977 118
1978 100
1979 97
1980 95
1981 126
1982 133
1983 134
1984 160
1985 146
1986 169
1987 215
1988 210
1989 246
1990 174
1991 197
1992 169
1993 164
1994 175
1995 182
1996 178
1997 182
1998 183
1999 193
2000 229
2001 229
2002 234
2003 224
2004 221
2005 265
2006 310
2007 327
2008 293
2009 328
2010 393
2011 383
2012 462
2013 500
2014 461
2015 474
2016 457
2017 470
2018 460
2019 468
2020 558
2021 631
2022 580
2023 539
2024 248

Text availability

Article attribute

Article type

Publication date

Search Results

14,200 results

Results by year

Filters applied: . Clear all
Page 1
The Diagnosis and Management of Neurofibromatosis Type 1.
Ly KI, Blakeley JO. Ly KI, et al. Med Clin North Am. 2019 Nov;103(6):1035-1054. doi: 10.1016/j.mcna.2019.07.004. Med Clin North Am. 2019. PMID: 31582003 Review.
Neurofibromatosis type 1 (NF1), NF2, and schwannomatosis are related, but distinct, tumor suppressor syndromes characterized by a predilection for tumors in the central and peripheral nervous systems. ...
Neurofibromatosis type 1 (NF1), NF2, and schwannomatosis are related, but distinct, tumor suppressor syndromes characte …
Neurofibromatosis type 1: a multidisciplinary approach to care.
Hirbe AC, Gutmann DH. Hirbe AC, et al. Lancet Neurol. 2014 Aug;13(8):834-43. doi: 10.1016/S1474-4422(14)70063-8. Lancet Neurol. 2014. PMID: 25030515 Free article. Review.
Neurofibromatosis type 1 is a relatively common inherited disorder. Patients have a high predisposition to develop both benign and malignant tumours. Although many manifestations of neurofibromatosis type 1 affect the nervous system, othe …
Neurofibromatosis type 1 is a relatively common inherited disorder. Patients have a high predisposition to develop both …
Health Supervision for Children With Neurofibromatosis Type 1.
Miller DT, Freedenberg D, Schorry E, Ullrich NJ, Viskochil D, Korf BR; COUNCIL ON GENETICS; AMERICAN COLLEGE OF MEDICAL GENETICS AND GENOMICS. Miller DT, et al. Pediatrics. 2019 May;143(5):e20190660. doi: 10.1542/peds.2019-0660. Pediatrics. 2019. PMID: 31010905 Review.
Neurofibromatosis type 1 (NF1) is a multisystem disorder that primarily involves the skin and peripheral nervous system. ...
Neurofibromatosis type 1 (NF1) is a multisystem disorder that primarily involves the skin and peripheral nervous system …
Neurofibromatosis type 1.
Cimino PJ, Gutmann DH. Cimino PJ, et al. Handb Clin Neurol. 2018;148:799-811. doi: 10.1016/B978-0-444-64076-5.00051-X. Handb Clin Neurol. 2018. PMID: 29478615 Review.
The neurofibromatoses are a group of three heterogeneous disorders that include neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2), and schwannomatosis. ...
The neurofibromatoses are a group of three heterogeneous disorders that include neurofibromatosis type 1 (NF1), neurofi …
Cutaneous manifestations in neurofibromatosis type 1.
Miraglia E, Moliterni E, Iacovino C, Roberti V, Laghi A, Moramarco A, Giustini S. Miraglia E, et al. Clin Ter. 2020 Sep-Oct;171(5):e371-e377. doi: 10.7417/CT.2020.2242. Clin Ter. 2020. PMID: 32901776 Free article. Review.
OBJECTIVE: To better understand the real prevalence of cutaneous manifestations, in Neurofibromatosis type 1. MATERIALS AND METHODS: We reviewed all clinical charts of 1102 NF1 patients followed by February 1983 to February 2020 at the "Sapienza" University o …
OBJECTIVE: To better understand the real prevalence of cutaneous manifestations, in Neurofibromatosis type 1. MATERIALS …
Neurofibromatosis type 1 (NF1): diagnosis and management.
Ferner RE, Gutmann DH. Ferner RE, et al. Handb Clin Neurol. 2013;115:939-55. doi: 10.1016/B978-0-444-52902-2.00053-9. Handb Clin Neurol. 2013. PMID: 23931823 Review.
Neurofibromatosis 1 (NF1) is an inherited neurocutaneous disease that has a major impact on the nervous system, eye, skin, and bone. ...
Neurofibromatosis 1 (NF1) is an inherited neurocutaneous disease that has a major impact on the nervous system, eye, skin, and …
Neurofibromatosis type 1 system-based manifestations and treatments: a review.
Saleh M, Dib A, Beaini S, Saad C, Faraj S, El Joueid Y, Kotob Y, Saoudi L, Emmanuel N. Saleh M, et al. Neurol Sci. 2023 Jun;44(6):1931-1947. doi: 10.1007/s10072-023-06680-5. Epub 2023 Feb 24. Neurol Sci. 2023. PMID: 36826455 Review.
INTRODUCTION: Neurofibromatosis type 1 (NF1) is a genetic disorder caused by a mutation in the NF1 gene. ...
INTRODUCTION: Neurofibromatosis type 1 (NF1) is a genetic disorder caused by a mutation in the NF1 gene. ...
Neurofibromatosis type 1.
Anderson JL, Gutmann DH. Anderson JL, et al. Handb Clin Neurol. 2015;132:75-86. doi: 10.1016/B978-0-444-62702-5.00004-4. Handb Clin Neurol. 2015. PMID: 26564071 Review.
Neurofibromatosis type 1 (NF1), previously known as von Recklinghausen disease, is a neurogenetic disorder distinct from neurofibromatosis type 2 (NF2). ...
Neurofibromatosis type 1 (NF1), previously known as von Recklinghausen disease, is a neurogenetic disorder distinct fro …
Spinal manifestations of Neurofibromatosis type 1.
Shofty B, Barzilai O, Khashan M, Lidar Z, Constantini S. Shofty B, et al. Childs Nerv Syst. 2020 Oct;36(10):2401-2408. doi: 10.1007/s00381-020-04754-9. Epub 2020 Jun 20. Childs Nerv Syst. 2020. PMID: 32564155 Review.
BACKGROUND: Neurofibromatosis type 1 (NF1) patients may present a wide spectrum of spinal pathologies. ...
BACKGROUND: Neurofibromatosis type 1 (NF1) patients may present a wide spectrum of spinal pathologies. ...
Novel molecular targeted therapies for patients with neurofibromatosis type 1 with inoperable plexiform neurofibromas: a comprehensive review.
Solares I, Viñal D, Morales-Conejo M, Rodriguez-Salas N, Feliu J. Solares I, et al. ESMO Open. 2021 Aug;6(4):100223. doi: 10.1016/j.esmoop.2021.100223. Epub 2021 Aug 10. ESMO Open. 2021. PMID: 34388689 Free PMC article. Review.
Neurofibromatosis type 1 (NF1) is a genetic disorder that carries a higher risk of tumor development. ...
Neurofibromatosis type 1 (NF1) is a genetic disorder that carries a higher risk of tumor development. ...
14,200 results
You have reached the last available page of results. Please see the User Guide for more information.